A novel, once-nightly formulation of sodium oxybate is safe and effective for treating both subjective and objective symptoms of narcolepsy, new research suggests. Top-line results from the phase 3 REST-ON trial released earlier this year showed that the agent known…
Read More
Anafranil
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ANAFRANIL® clomipramine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Anafranil. It does not contain all the available information….
Read More